Cross-sectional evaluation of socioeconomic and clinical factors and the impact of fibromyalgia on the quality of life of patients during the COVID-19 pandemic

Abstract BACKGROUND: The fibromyalgia impact questionnaire (FIQ) relates to the functional capacity, professional situation, psychological disorders, and physical symptoms, and can identify the factors that determine the impact of the syndrome and characteristics of its carriers; the higher the score, the greater the impact of fibromyalgia on the quality of life. OBJECTIVE: To evaluate the impact of fibromyalgia on the quality of life of individuals with fibromyalgia, who were categorized according to the FIQ during the coronavirus disease pandemic. DESIGN AND SETTING: A cross-sectional study was conducted at an institution of higher education in Taquara, RS, Brazil. METHODS: A quantitative study was carried out, with the application of a sociodemographic and clinical questionnaire, and the FIQ in 163 Brazilian individuals with a medical diagnosis of fibromyalgia. Data were collected using SurveyMonkey software. RESULTS: Of the female carriers, 98.2% were living in urban areas, working, and under pharmacological and complementary treatment. The FIQ results showed that seven of the 10 items had the maximum score. The items "physical function" and "feel good" had intermediate scores, and the item "missed work" had a low score. The average total score was 79.9 points, indicating that fibromyalgia had a severe impact on the participants' lives. A severe impact of fibromyalgia was observed in 61.3% of the participants, a moderate impact in 30.7%, and a low impact in 8%. CONCLUSION: The survey findings suggest a severe impact in the majority of the Brazilian fibromyalgic population.

The knowledge of prescription and the pharmacological role in temporomandibular disorders for dental surgeons: literature review / O conhecimento da prescrição e o papel farmacológico em disfunção temporomandibular para os cirurgiões-dentistas: revisão de literatura

ABSTRACT BACKGROUND AND OBJECTIVES: The temporomandibular disorder (TMD) is an anatomical-functional disorder that affects the muscles of chewing, the temporomandibular joint (TMJ) or both structures. It is one of the most common orofacial pain of non-dental origin with a prevalence of 5% to 7% of the population, being considered a public's health problem. The main symptom of TMD is pain and, when chronic, it affects the quality of life. The drug classes that are commonly used in this condition are antidepressants, anticonvulsants and muscle relaxants that modulate symptomatology in these subjects. The aim of this study was to review the literature about main drugs used to control TMD, its mechanisms of action and effectiveness as well as the possible causes of TMD. CONTENTS: Literature was searched in the following databases: Pubmed, Scielo and Lilacs with a time sample from 2010 to 2021. As inclusion parameter, were selected literatures review and systematic articles, randomized clinical cases, placebo-controlled and double-blind studies with the TMD theme, considering pharmacological treatments aspects. As exclusion parameter, articles in which the outcome was not the TMD, congress abstracts and personal opinions were rejected. After the articles' selection, reading of titles and abstracts, 09 articles were selected, consisting of reviews and clinical studies relevant to the subject. CONCLUSION: The pharmacological approach has demonstrated its positive effects in the management of TMD-related chronic pain, with more effective results when associated with other therapies, due to its multifactorial characteristic.

RESUMO JUSTIFICATIVA E OBJETIVOS: A disfunção temporomandibular (DTM) é uma desordem anátomo-funcional que afeta os músculos da mastigação, da articulação temporomandibular (ATM) ou ambas as estruturas. E uma das dores orofaciais mais comuns de origem não dentária, com prevalência de 5% a 7% da população, sendo considerada um problema de saúde pública. O principal sintoma da DTM é a dor que, quando crônica, afeta a qualidade de vida. As classes de fármacos mais comumente empregadas nessa condição são os antidepressivos, anticonvulsivantes e relaxantes musculares, que modulam os sintomas nesses pacientes. O objetivo deste estudo foi revisar a literatura acerca dos principais fármacos utilizados no controle da DTM, seus mecanismos de ação e eficácia, bem como as suas possíveis causas. CONTEÚDO: Buscou-se na literatura artigos científicos nas bases de dados: Pubmed, Scielo e Lilacs, com a amostra temporal de 2010 a 2021. Como parâmetro de inclusão, foram selecionados artigos de revisão de literatura e sistemática, casos clínicos randomizados, estudos placebo-controlados e estudos duplo-cegos com a temática DTM, considerando aspectos do tratamento farmacológico. Como parâmetro de exclusão, artigos em que o desfecho não era a DTM, resumos em congressos e opiniões pessoais foram rejeitados. Após a seleção dos artigos, leitura de títulos e resumos, 9 artigos foram selecionados, consistindo em revisões e estudos clínicos pertinentes ao assunto. CONCLUSÃO: A abordagem farmacológica demonstrou efeitos positivos no manejo da dor crônica em DTM, tendo resultados mais eficazes quando associada a outras terapias, em virtude de sua característica multifatorial.

Use of medical cannabis in the treatment of endometriosis / Utilização da cannabis medicinal no tratamento da endometriose

ABSTRACT BACKGROUND AND OBJECTIVES: Endometriosis is a common gynecological condition, which affects 10% to 15% of women in the reproductive period and up to half of women with chronic pelvic pain and/or infertility. It is estimated that the number of women with endometriosis is 8 million in Brazil and more than 190 million worldwide. In industrialized countries, it is one of the main causes of gynecological hospitalization. The objective of this study was to evaluate the medical literature on the use of cannabis in the treatment of endometriosis. CONTENTS: Cannabis is increasingly available for the treatment of chronic pain, but its effectiveness remains uncertain due to the lack of randomized trials. CONCLUSION: Limited evidence suggests that cannabis may relieve pain in some patients, but there is insufficient evidence regarding dose, formulations and best route of administration that precludes a definitive recommendation on cannabis for the relief of chronic pelvic pain of gynecological origin.

RESUMO JUSTIFICATIVA E OBJETIVOS: A endometriose é uma afecção ginecológica comum que atinge de 10% a 15% das mulheres no período reprodutivo e até metade das mulheres com dor pélvica crônica e/ou infertilidade. Estima-se que o número de mulheres com endometriose seja de 8 milhões no Brasil e de mais de 190 milhões no mundo. Em países industrializados, é uma das principais causas de hospitalização ginecológica. O objetivo deste estudo foi avaliar a literatura médica sobre o uso da cannabis no tratamento da endometriose. CONTEÚDO: A cannabis está cada vez mais disponível para o tratamento da dor crônica, mas sua eficácia permanece incerta devido à insuficiência de estudos randomizados. CONCLUSÃO: As evidências limitadas sugerem que a cannabis pode aliviar a dor em alguns pacientes, mas existem evidências insuficientes em relação a dose, formulações e melhor via de administração, o que impede uma recomendação definitiva da cannabis para alívio da dor pélvica crônica de origem ginecológica.

Eficácia e segurança da alfa-agalsidase e a beta-agalsidase para intervenção na doença de Fabry: revisão rápida / Effectiveness and safety of agalsidase alfa and agalsidase beta for intervention in fabry disease: rapid review

Tecnologia: Alfa-agalsidase e/ou beta-agalsidase, comparada aos cuidados paliativos e ao tratamento sintomático associado aos órgãos alvos da doença de Fabry. Indicação: Manejo e intervenção aos desfechos clínicos em pacientes com a doença de Fabry. Pergunta: A intervenção por alfa-agalsidase e/ou beta-agalsidase é mais eficaz e segura que o manejo para o tratamento de sintomas ou paliativo aos desfechos clínicos esperados para a doença de Fabry? Métodos: Estudo de revisão sistemática rápida. A base consultada foi a Medline/Pubmed por meio de estratégias de buscas predefinidas. Foi feita avaliação da qualidade metodológica das revisões sistemáticas com a ferramenta AMSTAR-2 (Assessing the Methodological Quality of Systematic Reviews version 2). Resultados: Foram selecionadas 3 revisões sistemáticas, que atendiam aos critérios de inclusão. Conclusão: A intervenção com alfa-agalsidase e/ou beta-agalsidase promove redução para acúmulo de globotriaosilceramida; no entanto a redução é dependente do período de intervenção e concentração do fármaco, assim como o tecido avaliado e o tempo de sinais clínicos da doença. Há evidências de melhora na função renal, dor, desconfortos gastrointestinais e qualidade de vida. É importante considerar a heterogeneidade para as diferentes características dos grupos afetados, como idade, sexo e estágio da doença. No entanto, a compreensão consistente da relação tratamento e os desfechos são afetados pela baixa frequência de pessoas atingidas, e isso diminui o poder para inferências entre os diferentes estudos, reportando para as limitações da geração de protocolos de intervenção mais robustos e assertivos. Portanto, há necessidade de se seguir com novas avaliações, sobretudo para os estudos clínicos aleatorizados

Technology: Alphagalsity and/or beta-agalsidase compared to palliative care and symptomatic treatment associated with target organs in Fabry disease. Indication: Management and intervention to clinical outcomes in patients with Fabry disease. Question: Is alfagalsidase and/or beta-agalsidase intervention more effective and safer than management to treat symptoms or palliate expected clinical outcomes for Fabry disease? Methods: Rapid systematic review. Medline/Pubmed was consulted using predefined search strategies. The methodological quality of systematic reviews was assessed using the AMSTAR-2 (Assessing the Methodological Quality of Systematic Reviews version 2) tool. Results: Three systematic reviews were selected that met the inclusion criteria. Conclusion: Intervention with alfagalsidase and/or beta-agalsidase promotes a reduction in the accumulation of globotriaosylceramide; however, the reduction is dependent on the period of intervention and concentration of the drug, as well as the evaluated tissue and the time of clinical signs of the disease. There is evidence for improvements in kidney function, pain, gastrointestinal discomfort and quality of life. It is important to consider heterogeneity for different characteristics of affected groups, such as age, sex and disease stage; however, the consistent understanding of the relationship between treatment and outcomes is affected by the low frequency of people affected, and this reduces the power for inferences between different studies, referring to the limitations of generating more robust and assertive intervention protocols. There is therefore a need to continue with new assessments, especially for randomized clinical studies

Pharmacological treatments for children with infantile spasms / 中华实用儿科临床杂志

Infantile spasms is the most prevalent epileptic encephalopathy, and its prognosis is often poor.The fundamentals of treatment include early diagnosis and intervention, as well as long-term rehabilitation management.Pharmaceutical treatment is regarded as the primary and most important treatment for infantile spasms.Most importantly, it is based upon a standardized drug selection and administration.This article outlined the clinical application and progress of pharmacological therapy for the infantile spasms.

A longitudinal study of the peripheral and central auditory pathways in individuals with acute lymphoid leukemia

Abstract Objective To characterize the peripheral and central auditory pathways in individuals with Acute Lymphoid Leukemia (ALL) and compare assessment results before and during chemotherapy. Method The study included 17 subjects with ALL, divided into two age groups: 3 to 6 (11 individuals) and 7 to 16 years old (6 individuals). Each subject was evaluated twice (before and 3 to 6 months after chemotherapy treatment) with the following procedures: medical history survey, otoscopy, Pure-Tone Threshold (PTA) and speech audiometry, acoustic immittance measures, Brainstem Auditory Evoked Potentials (BAEP) and Long-Latency Auditory Evoked Potentials (LLAEP). Results PTA was normal. Tympanometry was abnormal in the second assessment in 2 individuals aged 3 to 6 years. One subject in each age group had absent ipsilateral acoustic reflexes. In high-frequency audiometry, 1 individual had abnormal results. BAEP was abnormal in 5 (first assessment) and 7 individuals (second assessment) aged 3 to 6 years and 2 (first assessment) and 1 individual (second assessment) aged 7 to 16 years. As for LLAEP, P1 latency was increased in 5 (first assessment) and 7 individuals (second assessment) aged 3 to 6 years. Conclusion No hearing loss was identified in the behavioral audiological assessment. BAEP was more affected in the 3-to-6-year-old group, with greater impairment in the lower brainstem in the first and second assessments. In LLAEP, P1 was the most impaired component in children aged 3 to 6 years, and P2 and N2 were so for those 7 to 16 years old, especially in the second assessment.

Bumetanide in autism spectrum disorder / Bumetanida no transtorno do espectro autista / Bumetanida en el trastorno del espectro autista

Objectives: This study aimed to make a bibliographic update on the already published data on bumetanide, addressing the main information on its use in Autism Spectrum Disorder (ASD). Methods: This was an integrative narrative review in which the following databases were used: Web of Science, MEDLINE, ScienceDirect, and Scielo. The descriptors used were: Autism Spectrum Disorder, Autistic Disorder and Bumetanide. It was considered only articles published in English and French. Original articles, randomized clinical trials, case reports, and review articles were included. Results: The results show that the use of bumetanide alters regions of the brain linked to the positive development of language, improvement of visual contact, improvement in social interactions, among others. Studies are also concerned about the safety and efficacy of bumetanide in ASD since several adverse effects have been reported. The most frequent were hypokalemia, polyuria, and loss of appetite. Conclusion: Bumetanide has proven as effective in improving some important symptoms in ASD, especially linked to language and social interaction, however, studies with larger groups of patients and with longer treatment and observation time are needed to confirm the efficacy and clarify the safety profile in use for people with ASD.

Objetivo: O objetivo deste trabalho foi fazer uma atualização bibliográfica sobre os dados já publicados da bumetanida, abordando as principais informações sobre seu uso no Transtorno do Espectro Autista (TEA). Metodologia: Foi realizada uma revisão do tipo narrativa integrativa, da qual foram utilizadas as bases de dados: Web of Science, MEDLINE, ScienceDirect e Scielo, com a utilização dos seguintes descritores: Autism Spectrum Disorder, Autistic Disorder e Bumetanide. Foram considerados apenas artigos publicados nas línguas inglesa e francesa. Foram incluídos artigos originais, ensaios clínicos randomizados e relatos de caso. Foram excluídos artigos de revisão. Resultados: Os resultados mostram que o uso da bumetanida altera regiões do cérebro ligadas ao desenvolvimento positivo da linguagem, melhora do contato visual, melhora nas interações sociais, entre outros. Os estudos também se preocupam em relacionar a segurança e a eficácia da bumetanida no TEA, do qual foram relatados diversos efeitos adversos, sendo os mais frequentes a hipocalemia, a poliúria e a perda de apetite. Conclusão: A bumetanida mostrou ser eficaz na melhoria de alguns importantes sintomas no TEA, especialmente ligados à linguagem e interação social, entretanto, estudos com grupos maiores de pacientes e com maior tempo de tratamento e observação são necessários para confirmar a eficácia e esclarecer o perfil de segurança no uso para pessoas com TEA.

: Este estudio tuvo como objetivo realizar una actualización bibliográfica sobre los datos ya publicados sobre la bumetanida, abordando la principal información sobre su uso en el Trastorno del Espectro Autista (TEA). Métodos: Se trata de una revisión narrativa integradora en la que se utilizaron las siguientes bases de datos: Web of Science, MEDLINE, ScienceDirect y Scielo. Los descriptores utilizados fueron: Trastorno del Espectro Autista, Trastorno Autista y Bumetanida. Se consideraron sólo los artículos publicados en inglés y francés. Se incluyeron artículos originales, ensayos clínicos aleatorios, informes de casos y artículos de revisión. Resultados: Los resultados muestran que el uso de la bumetanida altera regiones del cerebro relacionadas con el desarrollo positivo del lenguaje, la mejora del contacto visual, la mejora de las interacciones sociales, entre otros. Los estudios también se preocupan por la seguridad y eficacia de la bumetanida en el TEA, ya que se han reportado varios efectos adversos. Los más frecuentes fueron la hipocalemia, la poliuria y la pérdida de apetito. Conclusiones: La bumetanida ha demostrado ser eficaz en la mejora de algunos síntomas importantes en el TEA, especialmente vinculados al lenguaje y la interacción social, sin embargo, se necesitan estudios con grupos más grandes de pacientes y con mayor tiempo de tratamiento y observación para confirmar la eficacia y aclarar el perfil de seguridad en el uso para personas con TEA.

Dolor de espalda. Generalidades en su diagnóstico y tratamiento / Generalities of Back Pain in Diagnosis And Treatment

Introducción: El dolor de espalda es un síntoma frecuente y de distribución universal que afecta a personas de cualquier edad y de ambos sexos. El 80 % de la población presentará un dolor de espalda en algún momento de su vida. Los procesos agudos son autolimitados y se resuelven en el plazo de unas semanas, excepto algunos casos que se cronifican y requieren asistencia médica continuada. Los cuadros crónicos son más frecuentes en edades comprendidas entre 45 y 65 años y en el sexo femenino. Objetivo: Actualizar los elementos generales relacionados con el diagnóstico y tratamiento del dolor de espalda. Métodos: Se realizó una revisión detallada en la literatura en relación al dolor de espalda en cuanto a su diagnóstico y tratamiento. Se obtuvo literatura actualizada en las bases de datos Cumed, Ibec, Lilac, Pubmed/Medline, Scopus y Wholis. Se hizo una revisión del tema fundamentalmente de los últimos 5 años. Conclusiones: El dolor de espalda es un síntoma frecuente y de distribución universal que afecta a personas de cualquier edad y de ambos sexos. Las recomendaciones presentadas están basadas en la mejor evidencia disponible, con la intención de estandarizarlas para el tratamiento del dolor de espalda en la Atención Primaria de Salud y para el tratamiento farmacológico y no farmacológico(AU)

Introduction: Back pain is a frequent and universally distributed symptom that affects people of any age and of both sexes. 80% of the population will experience back pain at some point in their lives. Acute processes are self-limiting and resolve within a few weeks, except for some cases that become chronic and require continued medical care. Chronic symptoms are more frequent in ages between 45 and 65 years and in the female sex. Objective: To update the general elements related to the diagnosis and treatment of back pain. Methods: A detailed review of the literature was carried out in relation to back pain in terms of diagnosis and treatment. Updated literature was retrieved from Cumed, Ibec, Lilac, Pubmed/Medline, Scopus, and Wholis databases. A review of the subject was made fundamentally of the last 5 years. Conclusions: Back pain is a frequent and universally distributed symptom that affects persons of any age and both sexes. The recommendations are based on the best available evidence, with the intention of standardizing them for treating back pain in Primary Health Care and for pharmacological and non-pharmacological treatment(AU)

Reacciones adversas en personas vacunadas contra la COVID-19 pertenecientes al Recinto Umpechico, Ecuador / Adverse reactions in people vaccinated against COVID-19 belonging to the Recinto Umpechico, Ecuador / Reações adversas em pessoas vacinadas contra COVID-19 pertencentes ao Recinto Umpechico, Equador

RESUMEN Introducción: Las vacunas contra la COVID-19 estimulan procesos inmunitarios que permiten mitigar el SARS-CoV-2, que afectó a gran parte de la población. Las investigaciones de las reacciones adversas presentadas por las vacunas de la COVID-19 deben ser continuas, ya que en la actualidad no existe información suficiente sobre sus consecuencias. Objetivo: Determinar las posibles reacciones adversas en adultos jóvenes y mayores pertenecientes al Recinto Umpechico inoculados contra el SARS-CoV-2 en Santo Domingo, durante el transcurso de 2021. Método: Se elaboró un estudio descriptivo en una población de 600 moradores de dicha localidad inoculados contra el SARS-CoV-2. Se empleó un muestreo no probabilístico por conveniencia cuya muestra fue de 235 habitantes. Las variables del estudio fueron: reacciones adversas de las vacunas contra la COVID-19, nombre de la vacuna recibida, número de dosis, intensidad y tiempo de duración de los síntomas, medicamentos utilizados para mitigar dichas reacciones adversas. Resultados: El 31,5 % de los encuestados que presentaron síntomas fueron de género masculino. La vacuna más aplicada fue Pfizer con 47,65 %, con un porcentaje de síntomas del 29,36 %. La reacción adversa más presentada fue dolor de brazo con un 31,98 %, con duración de dos a tres días equivalentes al 48,96 %; el 62,65 % usó paracetamol y el 20,5 % baños de agua fría para disminuir los síntomas. Conclusiones: Las vacunas fabricadas por las distintas casas farmacéuticas provocan reacciones adversas que van desde leves a graves, manifestándose a cualquier edad y a un corto o a largo plazo de duración, las cuales en la mayoría de los casos son fácilmente tratadas con medicamentos farmacológicos y no farmacológicos.

ABSTRACT Introduction: COVID-19 vaccines stimulate immune processes that allow SARS-CoV-2, which affected a large part of the population, to be mitigated. The research on the adverse reactions presented by the COVID-19 vaccines must be continuous, since at present there is not enough information on their consequences. Objective: To determine the possible adverse reactions in young and older adults belonging to the Recinto Umpechico, inoculated against SARS-CoV-2 in Santo Domingo, during 2021. Method: A descriptive study was carried out in a population of 600 residents of said locality, inoculated against SARS-CoV-2. Non-probability convenience sampling was used, with a sample of 235 inhabitants. The study variables were: adverse reactions to COVID-19 vaccines, name of the vaccine received, number of doses, intensity and duration of symptoms, medications used to mitigate said adverse reactions. Results: 31.5% of the respondents who presented symptoms were male. The most common vaccine was Pfizer with 47.65%, with a percentage of symptoms of 29.36%. The most common adverse reaction was arm pain with 31.98%, lasting two to three days, equivalent to 48.96%; 62.65% used paracetamol and 20.5% used cold water baths to reduce symptoms. Conclusions: The vaccines manufactured by the different pharmaceutical companies cause adverse reactions that range from mild to severe, manifesting at any age and for a short or long term, which in most cases are easily treated with pharmacological and non-pharmacological medications.

RESUMO Introdução: As vacinas COVID-19 estimulam processos imunológicos que permitem mitigar o SARS-CoV-2, que afetou grande parte da população. As investigações das reações adversas apresentadas pelas vacinas COVID-19 devem ser contínuas, pois atualmente não há informações suficientes sobre suas consequências. Objetivo: Determinar as possíveis reações adversas em adultos jovens e idosos pertencentes ao Campus Umpechico inoculados contra SARS-CoV-2, em Santo Domingo, durante o ano de 2021. Método: Estudo descritivo realizado em uma população de 600 moradores da referida localidade inoculada contra SARS-CoV-2. Foi utilizada uma amostragem não probabilística de conveniência, cuja amostra foi de 235 habitantes. As variáveis do estudo foram: reações adversas das vacinas COVID-19, nome da vacina recebida, número de doses, intensidade e duração dos sintomas, medicamentos utilizados para mitigar tais reações adversas. Resultados: 31,5% dos entrevistados que apresentaram sintomas eram do sexo masculino. A vacina mais aplicada foi a Pfizer com 47,65%, com percentual de sintomas de 29,36%. A reação adversa mais comum foi dor no braço com 31,98%, com duração de dois a três dias, equivalente a 48,96%; 62,65% usaram paracetamol e 20,5% usaram banhos de água fria para reduzir os síntomas. Conclusões: As vacinas fabricadas pelas diferentes empresas farmacêuticas causam reações adversas que variam de leves a graves, manifestando-se em qualquer idade e de curto ou longo prazo, que na maioria dos casos são facilmente tratadas com medicamentos farmacológicos e não farmacológicos.

Crisis suprarrenal: prevención, corticoterapia y elección del fármaco, revisión de la evidencia actual y recomendaciones / Adrenal crisis: prevention, corticotherapy and choice of the drug, review of current evidence and recommendations

INTRODUCCIÓN. La crisis suprarrenal se refiere a la insuficiencia suprarrenal aguda; la cual es un trastorno en el que la corteza adrenal no produce suficientes hormonas esteroides (en especial cortisol) para satisfacer las demandas del cuerpo, de acuerdo al mecanismo fisiopatológico se la puede clasificar como primaria, secundaria y terciaria, siendo más común en pacientes con insuficiencia suprarrenal primaria. Es una emergencia potencialmente mortal que requiere tratamiento inmediato. OBJETIVO. Establecer una estrategia de prevención y tratamiento de la crisis suprarrenal, así como la farmacoterapia ideal y sus alternativas válidas. MATERIAL Y MÉTODOS. Se realizó una revisión bibliográfica en varias revistas virtuales de alto carácter científico como Cochrane Library, Cochrane Systematic Reviews Database, MEDLINE a través de PubMed y ClinicalTrial.gov. Se seleccionaron revisiones sistemáticas con o sin metaanálisis, ensayos clínicos y recomendaciones de expertos relacionados con prevención y tratamiento de crisis suprarrenal en general. RESULTADOS. Se obtuvieron 1819 resultados, de los cuales se seleccionaron 20 artículos con mayor validez y replicabilidad en el medio para establecer un protocolo unificado de actuación. CONCLUSIÓN. El objetivo de la terapia es el tratamiento de la hipotensión y reversión de las anomalías electrolíticas y de la deficiencia de cortisol. Se deben infundir por vía intravenosa grandes volúmenes (1 a 3 litros) de solución salina al 0,9% o dextrosa al 5% en solución salina al 0,9% y la administración de hidrocortisona (bolo de 100 mg), seguido de 50 mg cada 6 horas (o 200 mg / 24 horas como infusión continua durante las primeras 24 horas). Si no se dispone de hidrocortisona, las alternativas incluyen prednisolona, prednisona y dexametasona.

INTRODUCTION. Adrenal crisis refers to acute adrenal insufficiency; which is a disorder in which the adrenal cortex does not produce enough steroid hormones (especially cortisol) to meet the body's demands, according to the pathophysiological mechanism it can be classified as primary, secondary and tertiary, being more common in patients with primary adrenal insufficiency. It is a life-threatening emergency that requires immediate treatment. OBJECTIVE. To establish a strategy for the prevention and treatment of adrenal crisis, as well as the ideal pharmacotherapy and its valid alternatives. MATERIAL AND METHODS. A literature review was performed in several highly scientific virtual journals such as Cochrane Library, Cochrane Systematic Reviews Database, MEDLINE through PubMed and ClinicalTrial.gov. Systematic reviews with or without meta-analysis, clinical trials and expert recommendations related to prevention and treatment of adrenal crisis in general were selected. RESULTS. A total of 1819 results were obtained, from which 20 articles with greater validity and replicability in the setting were selected to establish a unified protocol for action. CONCLUSIONS. The aim of therapy is the treatment of hypotension and reversal of electrolyte abnormalities and cortisol deficiency. Large volumes (1 to 3 liters) of 0.9% saline or 5% dextrose in 0.9% saline and administration of hydrocortisone (100 mg bolus), followed by 50 mg every 6 hours (or 200 mg / 24 hours as a continuous infusion for the first 24 hours) should be infused intravenously. If hydrocortisone is not available, alternatives include prednisolone, prednisone, and dexamethasone.

Cuidado clínico farmacêutico e estratégia para o uso racional e adesão ao tratamento em pacientes com hanseníase numa Policlínica do Recife / Pharmaceutical clinical care and strategy to rational use and adhesion to treatment in Hansen's disease patients at a policlinic from Recife

Introdução: a hanseníase é uma doença de fácil diagnóstico, possuindo tratamento e cura. Quando diagnosticada tardiamente, pode trazer graves consequências para os portadores e seus familiares. Uma vez que o tratamento da hanseníase está inserido no componente estratégico da assistência farmacêutica, são exigidos cuidados e orientação. Há necessidade de intervenção clínica farmacêutica, com objetivo de acompanhar prescrições medicamentosas, analisando a adesão dos pacientes ao tratamento com a promoção de ações de educação em saúde, além de minimizar a ocorrência de eventos adversos relacionados aos fármacos do tratamento com possível redução de custos associados aos agravos. Objetivo: realizar o monitoramento para identificar e tratar as possíveis intercorrências que estão comumente presentes no tratamento de hanseníase. Metodologia: a realização do estudo deu-se com o acompanhamento dos pacientes atendidos no serviço de referência a partir da aplicação de questionários em consultas periódic as, vis to que a adesão ao tratamento, reduç ão dos eventos adver sos e controle dos comunic antes são de suma impor tância para o controle epidemiológico. Resultados: os principais sintomas dos indivíduos acometidos foram dormência e eritema nodoso hansênico. A maioria utilizava como tratamento o esquema multibacilar e talidomida. O acometimento relatado dos pacientes foi em nível moderado. Os pacientes possuíam comorbidades como hipertensão, artrose e diabetes. O acompanhamento clínico foi relatado como positivo pela maioria dos entrevistados. Conclusão: o desfecho do estudo mostra que a adesão do paciente é crucial para o êxito do tratamento e o acompanhamento do farmacêutico clínico constitui um pilar positivo, contribuindo para a prevenção de agravos e conscientização da comunidade.

Introduction: Hansen's disease is an easily diagnosed disease, with treatment and cure available. When diagnosed late, it can bring serious consequences for patients and their families. Since the treatment of Hansen's disease is part of the strategic component of pharmaceutical assistance, care and guidance are required. There is a need for clinical pharmaceutical intervention, aiming to monitor drug prescriptions, analyze patients' adherence to treatment while promoting health education actions, in addition to minimizing the occurrence of adverse events related to treatment drugs with possible reduction in costs associated to grievances. Objective:thus, the present study aimed to monitor, identify, and treat possible complications commonly present in the treatment of Hansen's disease. Methodology: The study was carried out with the follow-up of patients seen at the reference service, through the application of questionnaires in periodic appointments, since adherence to treatment, reduction of adverse events and control of communicants are of short importance for epidemiological control. Results:The main symptoms of Hansen's disease patients were numbness and leprosy nodosum erythema. Most used the multibacillary scheme and thalidomide as treatment. The reported involvement of patients was at a moderate level. Patients had other comorbidities such as hypertension, arthrosis and diabetes. The clinical assistance was reported as positive by most interviewees. Conclusion: The outcome of the study shows that patient's compliance is crucial for the success of treatment and the clinical pharmacist's accompaniment is a positive pillar, contributing to the prevention of complications and community awareness.

Tratamiento no farmacológico y su acción sobre la musculatura esquelética en ancianos con sarcopenia / Non pharmacological treatment and its action on the skeletal musculature of elderly with sarcopenia

La sarcopenia es un síndrome geriátrico caracterizado por la pérdida generalizada y progresiva de la masa muscular esquelética, así como disminución de la fuerza muscular y del rendimiento físico. Al respecto, el tratamiento no farmacológico es de gran importancia por su acción en la musculatura esquelética. En este trabajo se precisan los elementos fundamentales para aplicar esta terapia en ancianos, cuya evaluación clínica incluye, entre otros, la valoración de comorbilidades crónicas y agudas y de su funcionalidad física mediante el índice de Katz y la escala de Lawton y Brody, el volumen de actividad física planificada y el diagnóstico de los estadios de sarcopenia por el estado de la masa muscular esquelética, según el European Working Group on Sarcopenia in Older People. También se proponen programas de ejercicios de fuerza y resistencia corroborados en metaanálisis, con una duración, frecuencia e intensidad establecidas, para fortalecer la musculatura esquelética y su acción sobre los cambios fisiopatológicos, a fin de lograr la adaptación muscular y mejorar la funcionalidad física; con ello, se previenen las caídas y fracturas en los ancianos con sarcopenia y se mejora su calidad de vida.

Sarcopenia is a geriatric syndrome characterized by the widespread and progressive loss of the skeletal muscular mass and decrease of the muscular force and physical performance. In this respect, the non-pharmacological treatment is of great importance due to its action in the skeletal musculature. In this work the fundamental elements to apply this therapy in elderly are specified whose clinical evaluation includes, among others, the valuation of chronic and acute comorbidities and of their physical functionality by means of the Katz index and the Lawton and Brody scale, the volume of planned physical activity and the diagnosis of the sarcopenia phases by the condition of the skeletal muscular mass, according to the European Working Group on Sarcopenia in Older People. Programs of force and resistance exercises corroborated in meta-analysis are also suggested, with an established duration, frequency and intensity, to strengthen the skeletal musculature and its action on the pathophysiological changes, in order to achieve the muscular adaptation and improve the physical functionality; with it, falls and fractures are prevented in the elderly with sarcopenia and improve their life quality.

Primary cutaneous B-cell lymphoma leg type: good response with the RADHAP 21 protocol

Abstract Primary cutaneous lymphomas are defined as the ones that exclusively affect the skin for up to 6 months after the diagnosis. B-cell lymphomas represent 20-25% of primary cutaneous lymphomas and have, among its subtypes, the leg type, which represents 10 to 20% of cutaneous B-cell lymphomas, generally affecting elderly people and with an intermediate prognosis. This is the report of a rare case of a leg-type B-cell lymphoma with an exuberant clinical presentation affecting a young male patient.

A importância do Projeto Terapêutico Singular (PTS) no acompanhamento de usuários de um Centro de Atenção Psicossocial Álcool e Outras Drogas (CAPSad): relato de experiência / The importance of the Singular Therapeutic Project (PTS) in monitoring users of a Psychosocial Care Center for Alcohol and Other Drugs (CAPSad): experience report / La importancia del Proyecto Terapéutico Singular (PTS) en el seguimiento de usuarios de un Centro de Atención Psicosocial de Alcohol y Otras Drogas (CAPSad): relato de experiencia

Buscou-se relatar a experiência de um profissional de educação física no desenvolvimento de Projetos Terapêuticos Singulares (PTS) utilizados no acompanhamento de usuários em sofrimento mental de um CAPSad da região metropolitana Fortaleza-CE. Trata-se de uma pesquisa do tipo relato de experiência com abordagem qualitativa realizada de janeiro de 2021 a fevereiro de 2022. Os resultados indicam que a participação do profissional de educação física residente foi de grande importância desde o planejamento do PTS junto às equipes multidisciplinares aos acompanhamentos individuais e/ou coletivos dos usuários e seus familiares no contexto de recuperação. O cuidado integral e participativo contribuiu no desenvolvimento da autonomia dos sujeitos rumo à responsabilização do próprio cuidado.

It was sought to report the experience of a physical education professional in the development of Singular Therapeutic Projects (PTS) used in the follow-up of users in mental suffering of a CAPSad in the metropolitan region of Fortaleza-CE. This is an experience report type research with a qualitative approach carried out from January 2021 to February 2022. The results indicate that the participation of the resident physical education professional was of great importance from the planning of the PTS with the multidisciplinary teams to the individual and/or collective follow-ups of users and their families in the context of recovery. Comprehensive and participatory care contributed to the development of subjects' autonomy towards accountability for their own care.

Buscamos relatar la experiencia de un profesional de educación física en el desarollo de Proyectos Terapéuticos Singulares (PTS) utilizados en el acompañamiento de usuarios en sufrimiento psíquico de un CAPSad en la región metropolitana de Fortaleza-CE. Se trata de una investigación tipo relato de experiencia con abordaje cualitativo realizada de enero de 2021 a febrero de 2022. Los resultados indican que la participación del profesional residente de educación física fue de gran importancia desde la planificación del PTS con los equipos multidisciplinarios hasta el individual y /o seguimientos colectivos de usuarios y sus familias en el contexto de la recuperación. El cuidado integral y participativo contribuyó al desarrollo de la autonomía de los sujetos hacia la responsabilidad por su propio cuidado.

Validación del instrumento para determinación de prevalencia de celulitis facial y su relación con la caries dental en pacientes de 5 a 9 años de edad / Validation of the instrument for the determination of prevalence of facial cellulite and its relationship with cariesdental in patients from 5 to 9 years of age

La celulitis facial odontogénica es comúnmente observada en las salas de emergencia hospitalarias en los pacientes pediátricos debido a la caries dental. Objetivo: Validar el instrumento de prevalencia de celulitis facial y su relación con la caries dental en pacientes de 5 a 9 años de edad en el Hospital General IESS Milagro. Materiales y métodos: Enfoque mixto cuantitativa y cualitativa, tipo de investigación de campo, corte transversal, descriptivo, no experimental, se realizó un plan piloto de 15 pacientes pediátricos, un instrumento cuantitativo (Ficha de recolección de datos) contó con 9 expertos para un juicio de expertos y en el instrumento cualitativo (Entrevista) contó con 6 expertos para la validación del instrumento en total son de 15 profesionales en salud, calificando Validez, Pertinencia y Coherencia. Resultados: El instrumento cuantitativo tiene una puntuación de 80,85 de confiablidad y el instrumento cualitativo tiene una puntuación de 87,11 de confiablidad. En el instrumento cuantitativo se determinó la prevalencia de celulitis facial de niños de 5 a 9 años de edad, género masculino (80%), rango de 7 a 8 años (53,3%), cita por primera vez (60%), antecedente referencial caries dental (93,3%), diagnóstico CIES10 fue el L032 celulitis de la cara (93,3%), región afectada en la zona submandibular (73,3%), prevalencia de caries dental, molares deciduos (93,3%), no registran antecedentes de buena salud (73,3%), tratamientos odontológicos de prevención al año ninguna (80%), causa frecuente en la aparición de celulitis facial, la necrosis pulpar K041. Conclusión: La validación del instrumento tuvo un grado de confiabilidad muy buena y su cifra de alfa de Cronbach alto, la misma que da seguridad y confianza, gracias a la calificación de los jueces que revisaron cada detalle(AU)

Odontogenic facial cellulite is commonly observed in hospital emergency rooms in pediatric patients due to the dental caries. Objective: to validate the facial cellulite prevalence instrument and its relationship with dental caries in patients from 5 to 9 years of age in the IESS Miracle General Hospital. Materials and methods: mixed approach quantitative and qualitative, type of field research, cross section, descriptive, non-experimental, a pilot plan of 15 patients was carried out ediatric patients, a quantitative instrument (data collection form) counted with 9 experts for an expert judgment and in the qualitative instrument (Interview) had 6 experts for the validation of the instrument in total they are of 15 health professionals, qualifying Validity, Relevance and Coherence. Results: the quantitative instrument has a score of 80.85 of reliability and the qualitative instrument has a score of 87.11 out of reliability. In the quantitative instrument, the prevalence of facial cellulite in children 5 to 9 years of age, male gender (80%), range 7 to 8 years old (53.3%), appointment for the first time (60%), referential history dental caries (93.3%), CIES10 diagnosis was L032 facial cellulite (93.3%), affected region in the submandibular area (73.3%), prevalence of dental caries, deciduous molars (93.3%), do not record a history of good health (73.3%), preventive dental treatments per year none (80%), frequent cause in the appearance of facial cellulitis, pulpal necrosis K041. Conclusion: the validation of the instrument had a very high degree of reliability. good and its high Cronbach's alpha figure, the same one that gives security and confidence, thanks to the rating of the judges who reviewed every detail(AU)

Reação adversa à isotretinoína: alteração do formato capilar / Adverse reaction to isotretinoin: alteration of the hair shaft structure

Embora pouco frequente na prática clínica, o uso de retinoides sistêmicos pode provocar alterações no formato, na coloração e textura das hastes capilares. Relatamos o caso de um paciente tratado com isotretinoína para acne vulgar que experimentou mudança do tipo capilar, de liso para encaracolado. Tais modificações são possíveis ao longo da terapia com retinoides orais; entretanto, a mudança do formato dos fios induzida pela isotretinoína é um fenômeno extremamente raro na literatura

Although little reported in daily practice, the use of systemic retinoids can cause changes in the shape, color, and texture of hair shafts. We report a case of a patient treated with isotretinoin for acne vulgaris who experienced new growing curly hair. Such hair changes are recognized during therapy with oral retinoids; however, isotretinoin-induced modifications on the hair fiber curvature are extremely rare.

Psychosocially-Assisted Pharmacological Treatment of Opioid Dependent Adults: A Systematic Review

Background: Opioid dependence is a conundrum that significantly contributes to global mortality, crimes, and transmission of diseases such as hepatitis (B and C), human immunodeficiency virus and perhaps, coronavirus disease 2019 (COVID-19). There are contradictory findings on the efficacy of psychosocially-assisted pharmacological treatment of opioid dependence in adults. Objective: The overall objective of this research is to investigate if psychosocially-assisted pharmacological therapy has significantly better effect than pharmacological therapy with regards treatment outcomes of opioid dependent adults. Methods: All methods employed in this study are in conformity with the preferred reporting items for systematic reviews and meta-analysis (PRISMA) framework for systematic review which involve identification, screening, eligibility and inclusion. This systematic review involved PubMed literature search on randomized controlled trials published between 1st January 2015 to 1st October 2021. Results: PubMed search yielded 5,216 articles which were screened using inclusion and exclusion criteria resulting in 19 articled being retained for data extraction. Of the 19 articles used in this study, 13 (68.4%) articles having a combined sample size of 1,928 (60.6%) showed that addition of psychosocial intervention to pharmacotherapy significantly improved abstinence from opioid abuse. Conclusion: The outcome of evaluation of the overall evidences presented in the 19 articles used in this study is that psychosocially-assisted pharmacological therapy is significantly better than pharmacological treatment with respect to enhancement of abstinence from opioid abuse among opioid-dependent adults. Additionally, this study has provided specific combinations of psychosocial and pharmacological treatment that can produce significant beneficial effect on opioid abstinence. The huge downturn in randomized controlled trials on treatment of opioid dependence among adults has been highlighted in this study.

Research progress of refractory tic disorders / 中华实用儿科临床杂志

Refractory tic disorders (RTD) are a recently emerging concept gradually formed in pediatric neurology/psychiatry.Currently, the concept and diagnostic criteria of RTD remain unclarified, and it is extremely difficult to treat RTD.In this article, the definition, clinical features, influence factors, diagnosis, differential diagnosis, pharmacological treatment and non-pharmacological treatment of RTD in children were reviewed.

Evaluación del conocimiento sobre atención de emergencias médicas en dos facultades odontológicas del Perú / Evaluation of knowledge on medical emergency care in two schools of dentistry in Peru

Introducción: Las emergencias son circunstancias de aparición súbita que pueden presentarse durante la atención odontológica y pueden comprometer la vida del paciente; por ello, es necesario tener conocimientos sobre su diagnóstico y tratamiento primario para estabilizar al paciente. Objetivo: Determinar el nivel de conocimientos sobre la atención de emergencias médicas en estudiantes de Odontología de dos universidades peruanas. Material y Métodos: Estudio transversal descriptivo en el cual participaron 134 estudiantes de 7mo a 10mo ciclo, provenientes de la Universidad Científica del Sur y la Universidad Norbert Wiener. Se evaluaron los conocimientos sobre la atención de emergencias médicas considerando 3 dimensiones: diagnóstico, primeros auxilios y tratamiento farmacológico. La evaluación fue realizada mediante un cuestionario validado previamente. Resultados: El nivel general de conocimientos sobre la atención de emergencias médicas en ambas universidades fue regular, con 69,8 por ciento de estudiantes de la Universidad Científica del Sur y 53,5 por ciento de estudiantes de la Universidad Norbert Wiener; sin embargo, hubo diferencia significativa entre ambas universidades. (p=0,034). Asimismo, se observó diferencia significativa en el conocimiento sobre el diagnóstico, a favor de la Universidad Científica del Sur (p<0,05), pero no se encontraron diferencias al evaluar los conocimientos sobre primeros auxilios y tratamiento farmacológico (p<0,05). Conclusiones: La evaluación general de conocimientos sobre la atención de emergencias médicas en estudiantes de Odontología de Universidad Científica del Sur y la Universidad Norbert Wiener fue predominantemente regular(AU)

Introduction: Emergencies are circumstances of sudden onset that can occur during dental care and can compromise the patient's life; therefore, it is necessary to have knowledge about its diagnosis and primary treatment to stabilize the patient. Objective: To determine the level of knowledge about medical emergency care in dental students from two universities in Lima (Peru) in 2019. Material and Methods: A descriptive cross-sectional study that included 134 students from 7th to 10th cycle from the Científica del Sur University and the Norbert Wiener University was conducted. Knowledge of medical emergency care was evaluated considering 3 dimensions: diagnosis, first aid, and pharmacological treatment. The evaluation was carried out using a previously validated questionnaire. Results: The general level of knowledge on medical emergency care in both universities was regular, with 69,8 percent of students from Científica del Sur University and 53,5 percent of students from Norbert Wiener University; however, there was a significant difference between both universities (p = 0.034). Likewise, a significant difference was observed in the knowledge about diagnosis in favor of the Científica del Sur University (p0.05). Conclusions: The overall level of knowledge on medical emergency care in dental students at Científica del Sur University and Norbert Wiener University was predominantly fair(AU)